Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese

Overview

Journal Nutrients

Date 2019 Mar 1

PMID 30813612

Citations 22

Authors

Lisa J Moran

Manny Noakes

Peter Clifton

Jon Buckley

Grant Brinkworth

Rebecca Thomson

Robert J Norman

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women. Weight management is a first-line treatment for PCOS according to international evidence-based guidelines. However, the factors associated with attrition or success in weight loss interventions are not known for women with PCOS. The objective of this study was to identify characteristics associated with attrition and weight loss success in women with PCOS and overweight or obesity undergoing weight loss interventions. Four randomised controlled clinical weight loss trials comprising energy restricted diets and/or exercise interventions of 2⁻8 months duration. The interventions were conducted over 2001⁻2007 in outpatient clinical research centres with = 221 premenopausal women with PCOS and overweight/obesity recruited through community advertisement. The main outcome measures were attrition and ≥5% weight loss at 2 months and study completion. Weight loss was 5.7 ± 2.9 kg at 2 months and 7.4 ± 5.3 kg after study completion ( < 0.001). Attrition was 47.1% and ≥5% weight loss occurred in 62.5% and 62.7% of women at 2 months and study completion respectively. Baseline depressive symptoms (OR 1.07 95% CI 0.88, 0.96, = 0.032) and lower appointment attendance by 2 months (OR 0.92 95% CI 0.88, 0.96, < 0.001) were independently associated with attrition. Lower appointment attendance over the whole study was independently associated with not achieving ≥5% weight loss at study completion (OR 0.95 95% CI 0.92, 0.99, = 0.020). Despite high attrition, successful weight loss was achieved by 63% of women with PCOS in a clinical research setting. Higher baseline depressive symptoms were associated with greater attrition and higher appointment attendance was associated with lower attrition and greater weight loss success. These finding have implications for development of successful weight management programs in PCOS.

Citing Articles

Modulation of hormonal, metabolic, inflammatory and oxidative stress biomarkers in women with polycystic ovary syndrome following combined (resistant and endurance) training: a randomized controlled trail.

Nasiri M, Monazzami A, Alavimilani S, Asemi Z BMC Endocr Disord. 2025; 25(1):1.

PMID: 39748376 PMC: 11697657. DOI: 10.1186/s12902-024-01793-0.

A qualitative analysis of factors influencing physical activity behaviour in women with PCOS: key learning for physical activity interventions and beyond.

Woodward A, Klonizakis M, Broom D, Cholerton R, Piercy H Health Educ Res. 2024; 40(1).

PMID: 39658268 PMC: 11840715. DOI: 10.1093/her/cyae040.

Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis.

He J, Ruan X, Li J Front Endocrinol (Lausanne). 2024; 15:1418933.

PMID: 39247914 PMC: 11377251. DOI: 10.3389/fendo.2024.1418933.

A prospective 12-month structured weight loss intervention in women with severe obesity and polycystic ovary syndrome: Impact of weight loss on eating behaviors.

Kataoka J, Stener-Victorin E, Schmidt J, Larsson I Acta Obstet Gynecol Scand. 2024; 103(8):1615-1624.

PMID: 38717931 PMC: 11266713. DOI: 10.1111/aogs.14867.

Exploring the physiological factors relating to energy balance in women with polycystic ovary syndrome: a scoping review.

Nguo K, McGowan M, Cowan S, Davidson Z, Pirotta S, Dordevic A Nutr Rev. 2024; 83(1):160-174.

PMID: 38345350 PMC: 11632379. DOI: 10.1093/nutrit/nuad169.

References

Ko H, Teede H, Moran L . Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Res Notes. 2016; 9:311. PMC: 4910192. DOI: 10.1186/s13104-016-2107-2. View

Teede H, Deeks A, Moran L . Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:41. PMC: 2909929. DOI: 10.1186/1741-7015-8-41. View

Holley T, Collins C, Morgan P, Callister R, Hutchesson M . Weight expectations, motivations for weight change and perceived factors influencing weight management in young Australian women: a cross-sectional study. Public Health Nutr. 2015; 19(2):275-86. PMC: 10271181. DOI: 10.1017/S1368980015000993. View

Moran L, Noakes M, Clifton P, Wittert G, Belobrajdic D, Norman R . C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 92(8):2944-51. DOI: 10.1210/jc.2006-2336. View

Knowler W, Fowler S, Hamman R, Christophi C, Hoffman H, Brenneman A . 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374(9702):1677-86. PMC: 3135022. DOI: 10.1016/S0140-6736(09)61457-4. View

Harrison C, Lombard C, Moran L, Teede H . Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2010; 17(2):171-83. DOI: 10.1093/humupd/dmq045. View

Leung A, Chan R, Sea M, Woo J . An Overview of Factors Associated with Adherence to Lifestyle Modification Programs for Weight Management in Adults. Int J Environ Res Public Health. 2017; 14(8). PMC: 5580624. DOI: 10.3390/ijerph14080922. View

Tolino A, Gambardella V, Caccavale C, DEttore A, Giannotti F, DAnto V . Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2005; 119(1):87-93. DOI: 10.1016/j.ejogrb.2004.06.043. View

Moroshko I, Brennan L, OBrien P . Predictors of dropout in weight loss interventions: a systematic review of the literature. Obes Rev. 2011; 12(11):912-34. DOI: 10.1111/j.1467-789X.2011.00915.x. View

10.

Moran L, Noakes M, Clifton P, Wittert G, Williams G, Norman R . Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr. 2006; 84(1):77-87. DOI: 10.1093/ajcn/84.1.77. View

11.

Moran L, Ko H, Misso M, Marsh K, Noakes M, Talbot M . Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013; 113(4):520-45. DOI: 10.1016/j.jand.2012.11.018. View

12.

Wieland L, Falzon L, Sciamanna C, Trudeau K, Brodney S, Schwartz J . Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people. Cochrane Database Syst Rev. 2012; (8):CD007675. PMC: 3996838. DOI: 10.1002/14651858.CD007675.pub2. View

13.

Clark A, Thornley B, Tomlinson L, Galletley C, Norman R . Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998; 13(6):1502-5. DOI: 10.1093/humrep/13.6.1502. View

14.

Somerset S, Graham L, Markwell K . Depression scores predict adherence in a dietary weight loss intervention trial. Clin Nutr. 2011; 30(5):593-8. DOI: 10.1016/j.clnu.2011.04.004. View

15.

McLean R, Morrison D, Shearer R, Boyle S, Logue J . Attrition and weight loss outcomes for patients with complex obesity, anxiety and depression attending a weight management programme with targeted psychological treatment. Clin Obes. 2016; 6(2):133-42. DOI: 10.1111/cob.12136. View

16.

Mitchell N, Furniss A, Helmkamp L, Van Pelt R . Factors Associated with Achievement of Clinically Significant Weight Loss by Women in a National Nonprofit Weight Loss Program. J Womens Health (Larchmt). 2017; 26(8):911-917. PMC: 5576220. DOI: 10.1089/jwh.2016.6264. View

17.

Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, FUTTERWEIT W . Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998; 83(6):1976-87. DOI: 10.1210/jcem.83.6.4990. View

18.

Robinson S, Chan S, Spacey S, Anyaoku V, Johnston D, Franks S . Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf). 1992; 36(6):537-43. DOI: 10.1111/j.1365-2265.1992.tb02262.x. View

19.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

20.

Stepto N, Cassar S, Joham A, Hutchison S, Harrison C, Goldstein R . Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013; 28(3):777-84. DOI: 10.1093/humrep/des463. View